Medications for Covid19
6 results
Actemra (tocilizumab)
(tocilizumab)Genentech, Inc.
Usage: ACTEMRA® (tocilizumab) is indicated for adults with moderately to severely active rheumatoid arthritis, giant cell arteritis, systemic sclerosis-associated interstitial lung disease, and for children aged 2 and older with polyarticular or systemic juvenile idiopathic arthritis. It also treats severe cytokine release syndrome and COVID-19 in hospitalized patients.
Olumiant (baricitinib)
(baricitinib)Eli Lilly and Company
Usage: OLUMIANT (baricitinib) is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis, COVID-19 requiring respiratory support, and severe alopecia areata. It is not recommended for use with other JAK inhibitors, biologic DMARDs, or potent immunosuppressants.
Paxlovid (nirmatrelvir and ritonavir)
(nirmatrelvir and ritonavir)Pfizer Laboratories Div Pfizer Inc
Usage: PAXLOVID is indicated for treating mild-to-moderate COVID-19 in adults at high risk for severe disease progression, including hospitalization or death. It is not approved for pre-exposure or post-exposure prophylaxis against COVID-19.
Pfizer-biontech covid-19 vaccine (covid-19 vaccine, mrna)
(covid-19 vaccine, mrna)Pfizer Manufacturing Belgium NV
Usage: The Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) is authorized for emergency use to provide active immunization against COVID-19, specifically for individuals aged 6 months to 11 years. It is not licensed for any other use.
Sunscreen plus mineral stick tinted (titanium dioxide, zinc oxide)
(Titanium Dioxide, Zinc Oxide)Lily Lee, MD
Usage: It seems that no specific drug information was provided in your request. Please provide the name of the drug or specific details from the label, and I will summarize its indications and usages for you.
Tocilizumab-anoh (tocilizumab)
(tocilizumab)CELLTRION USA, Inc.
Usage: Tocilizumab-anoh is indicated for treating moderately to severely active rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, and COVID-19 in hospitalized adults requiring supplemental oxygen or mechanical ventilation.